- Roche receives FDA clearance on its digital pathology solution for diagnostic use
- Roche and Hitachi High-Tech extend their 46-year partnership, paving the way for further breakthroughs in diagnostic testing
- Roche obtains CE Mark for first companion diagnostic to identify patients with HER2-low metastatic breast cancer eligible for ENHERTU
Key statistics
On Tuesday, Chugai Pharmaceutical Co Ltd (CHGCY:PNK) closed at 17.97, -20.52% below its 52-week high of 22.61, set on Mar 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 17.76 |
---|---|
High | 18.21 |
Low | 17.76 |
Bid | -- |
Offer | -- |
Previous close | 17.97 |
Average volume | 115.94k |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Annual div (ADY) | 0.2694 USD |
---|---|
Annual div yield (ADY) | 1.50% |
Div ex-date | Dec 27 2023 |
Div pay-date | Apr 12 2024 |
Data delayed at least 15 minutes, as of Jul 02 2024 21:32 BST.
More ▼